ES450681A1 - Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol. - Google Patents

Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol.

Info

Publication number
ES450681A1
ES450681A1 ES450681A ES450681A ES450681A1 ES 450681 A1 ES450681 A1 ES 450681A1 ES 450681 A ES450681 A ES 450681A ES 450681 A ES450681 A ES 450681A ES 450681 A1 ES450681 A1 ES 450681A1
Authority
ES
Spain
Prior art keywords
methyl
phenyl
blocade
butylaminopropoxy
adrenoceptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES450681A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES450681A1 publication Critical patent/ES450681A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES450681A 1975-08-15 1976-08-13 Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol. Expired ES450681A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1071475 1975-08-15

Publications (1)

Publication Number Publication Date
ES450681A1 true ES450681A1 (es) 1977-11-16

Family

ID=4366041

Family Applications (1)

Application Number Title Priority Date Filing Date
ES450681A Expired ES450681A1 (es) 1975-08-15 1976-08-13 Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol.

Country Status (28)

Country Link
US (1) US4434176A (es)
JP (2) JPS5223073A (es)
AT (1) AT363070B (es)
AU (1) AU505719B2 (es)
BE (1) BE845197R (es)
CA (1) CA1080720A (es)
CY (1) CY1225A (es)
DE (1) DE2635209C2 (es)
DK (1) DK152120C (es)
ES (1) ES450681A1 (es)
FI (1) FI63751C (es)
FR (1) FR2320743A2 (es)
GB (2) GB1575509A (es)
HK (1) HK35884A (es)
IE (1) IE43797B1 (es)
IL (2) IL50263A (es)
KE (1) KE3404A (es)
MY (1) MY8500135A (es)
NL (2) NL176362C (es)
NO (1) NO762735L (es)
NZ (1) NZ181764A (es)
PH (1) PH13356A (es)
PT (1) PT65477B (es)
SE (1) SE414633B (es)
SG (1) SG84883G (es)
SU (1) SU649313A3 (es)
YU (1) YU198876A (es)
ZA (1) ZA764883B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2830211A1 (de) * 1977-07-21 1979-02-01 Sandoz Ag Substituierte indol-derivate, ihre herstellung und verwendung
JPS58106499A (ja) * 1981-12-19 1983-06-24 株式会社東芝 燃料交換装置のクランプ解除機構
HU196125B (en) * 1985-02-05 1988-10-28 Sandoz Ag Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic
US5174210A (en) * 1990-04-27 1992-12-29 Heidelberger Druckmaschinen Aktiengesellschaft Preparation of the inking unit of a printing press for a change of printing job
EP0750608A1 (en) * 1994-01-28 1997-01-02 Cal International Limited Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
CN1812983A (zh) * 2003-05-30 2006-08-02 兰贝克赛实验室有限公司 取代的吡咯衍生物及其作为hmg－co抑制剂的用途
EP1948599A1 (en) * 2005-11-08 2008-07-30 Ranbaxy Laboratories Limited Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
CL2007000667A1 (es) * 2006-03-14 2008-03-14 Ranbaxi Lab Ltd Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
AU2007274724B2 (en) * 2006-07-14 2012-07-26 Ranbaxy Laboratories Limited Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3751429A (en) * 1970-03-24 1973-08-07 Sandoz Ltd 4-(3-amino-2-substituted propoxy)indole derivatives
CH532040A (de) * 1970-03-24 1972-12-31 Sandoz Ag Verfahren zur Herstellung neuer Indolderivate
SE375771B (es) * 1970-09-30 1975-04-28 Sandoz Ag
CH545783A (en) * 1971-01-07 1974-02-15 Novel indole derivs - prepn by reacting 4-(2-hydroxy-3-isopropylaminopropoxy) indoles and acid anhy-drides
CH545784A (en) * 1971-01-07 1974-02-15 Beta blocking and anti-arrhythmic indole derivs - prepd by catalytic de-benzylation of 4-(3-benzyl aminopropoxy) indoles

Also Published As

Publication number Publication date
YU198876A (en) 1982-05-31
JPS5223073A (en) 1977-02-21
NL930134I1 (nl) 1993-11-01
IL50263A0 (en) 1976-10-31
IE43797L (en) 1977-02-15
AT363070B (de) 1981-07-10
NL176362C (nl) 1985-04-01
NL176362B (nl) 1984-11-01
ATA602576A (de) 1980-12-15
IE43797B1 (en) 1981-06-03
FR2320743A2 (fr) 1977-03-11
PT65477A (fr) 1976-09-01
DE2635209C2 (de) 1983-01-27
HK35884A (en) 1984-05-04
DE2635209A1 (de) 1977-02-24
AU505719B2 (en) 1979-11-29
JPS568834B2 (es) 1981-02-25
NZ181764A (en) 1978-06-20
PH13356A (en) 1980-03-20
GB1575510A (en) 1980-09-24
SE7608865L (sv) 1977-02-16
US4434176A (en) 1984-02-28
GB1575509A (en) 1980-09-24
ZA764883B (en) 1978-03-29
FI63751B (fi) 1983-04-29
FR2320743B2 (es) 1978-11-17
KE3404A (en) 1985-02-01
SE414633B (sv) 1980-08-11
IL58163A0 (en) 1979-12-30
MY8500135A (en) 1985-12-31
CY1225A (en) 1984-04-06
NO762735L (es) 1977-02-16
FI762258A (es) 1977-02-16
FI63751C (fi) 1983-08-10
BE845197R (fr) 1977-02-14
DK152120B (da) 1988-02-01
SU649313A3 (ru) 1979-02-25
IL50263A (en) 1980-06-30
NL930134I2 (nl) 1996-11-01
NL7608902A (nl) 1977-02-17
AU1684176A (en) 1978-02-16
CA1080720A (en) 1980-07-01
PT65477B (fr) 1978-05-10
DK357576A (da) 1977-02-16
SG84883G (en) 1985-01-11
DK152120C (da) 1988-06-20
JPS5649318A (en) 1981-05-02

Similar Documents

Publication Publication Date Title
ES430709A1 (es) Procedimiento para la obtencion de un medio fungicida a ba-se de derivados de 1-propil-imidazol.
ES448475A1 (es) Procedimiento de preparacion de derivados triyodados del benceno.
ES450681A1 (es) Procedimiento para la produccion de derivados del 4-(3-al- quil-aminopropoxi-indol.
ES405983A1 (es) Procedimiento para la preparacion de derivados de fenileti-lamina fluoralcohilados.
SE7602144L (sv) Kvaternera imidazoliumforeningar
ES440426A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina.
ES397598A1 (es) Procedimiento para preparar compuestos organicos de azufre.
ES369571A1 (es) Procedimiento para la preparacion de 1,3,4-tiadiazolil-(2)-ureas..
ES8105730A1 (es) Un procedimiento para la preparacion de piridizinobenzodiazepinas
GB931923A (en) Process for inhibiting metal corrosion
ES389473A1 (es) Un procedimiento de preparacion de derivados de aminocarbo-nil-3 oxazolidinona-2.
ES446077A1 (es) Procedimiento para la produccion de derivados de 2-(1-pipe- racinil)-tiazol.
ES428267A1 (es) Procedimiento para la produccion de derivados de guanidina.
SE7408826L (es)
ES331791A1 (es) Procedimiento para la obtencion de poli-n-oxidos.
ES466682A1 (es) Procedimiento para la obtencion de derivados del acido inde-no - 2.1-b-tiopen-2-oxamico
ES470751A1 (es) Procedimiento de preparacion de nuevas piridazinilhidrazonasy de sus sales farmaceuticamente aceptables
SE7411096L (es)
IE791781L (en) 4, 5-methano-bufadienolide rhamnosides
DE3172309D1 (en) Substituted 3,5-diamino-1,2,4-oxadiazoles and 3,5-diamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them
GR74822B (es)
FI820240L (fi) Nytt framstaellningsfoerfarande foer 17alfa-hydroxi-17beta-hydroxiacetylsteroider och pao motsvarande saett erhaollna mellanprodukter
FR2312255B1 (es)
ES455731A1 (es) Procedimiento para la preparacion de benzamidas disustitui- das en las posiciones 2 y 5.
ES395530A1 (es) Procedimiento para la preparacion de nuevos derivados de a-cido acrilico.